“…Differentiating primary lung cancer from LM is of great clinical interest because of the profound differences in their prognostic and therapeutic implications [ 79 , 80 ]. Furthermore, a solitary pulmonary nodule may be more difficult to interpret in patients with a history of cancer, as it may be a primary lung tumor, a metastasis, or a benign lesion [ 81 , 82 , 83 ]. From an imaging viewpoint, the ability to recognize various diseases based on qualitative criteria relies on observer expertise and experience, whereas quantitative parameters, such as pulmonary nodule diameter and/or growth rate, are surrogate biomarkers of malignancy [ 84 , 85 , 86 , 87 ].…”